{{Rsnum
|rsid=181359
|Gene=UBE2L3
|Chromosome=22
|position=21574352
|Orientation=plus
|GMAF=0.2759
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=UBE2L3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 69.0 | 28.3 | 2.7
| HCB | 26.3 | 51.1 | 22.6
| JPT | 30.1 | 49.6 | 20.4
| YRI | 80.3 | 17.0 | 2.7
| ASW | 75.4 | 21.1 | 3.5
| CHB | 26.3 | 51.1 | 22.6
| CHD | 20.2 | 56.9 | 22.9
| GIH | 32.7 | 56.4 | 10.9
| LWK | 82.7 | 17.3 | 0.0
| MEX | 28.1 | 49.1 | 22.8
| MKK | 78.1 | 21.3 | 0.6
| TSI | 76.5 | 21.6 | 2.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21102463
|Trait=None
|Title=Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|RiskAllele=T
|Pval=5E-16
|OR=1.1000
|ORtxt=[1.06-1.15]
|OA=1
}}

{{PMID Auto
|PMID=22482804
|Title=Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci
|OA=1
}}

{{on chip | Affy GenomeWide 6}}